Research Article
Identification and Validation of FGF-Related Prognostic Signatures in Prostate Cancer
Table 1
Independent prognostic value of the risk model.
| Variables | Univariate analysis | Multivariable analysis | HR | 95% CI of HR | | HR | 95% CI of HR | |
| Risk score | Low risk | 2.5558 | 1.4898-4.3847 | 0.0007 | 2.329 | 1.3117-4.135 | 0.0039 | High risk | Gleason score | <8 | 3.8395 | 2.1328-6.912 | 0 | 2.156 | 1.0821-4.296 | 0.0289 | ≥8 | Lymph node stage | N0 | 1.9119 | 1.0676-3.4239 | 0.0293 | 1.085 | 0.5873-2.003 | 0.7951 | N1 | Tumor stage | T1-T2 | 5.0389 | 2.1619-11.744 | 0.0002 | 3.065 | 1.1375-8.259 | 0.0268 | T3-T4 | PSA | <10 | 9.3373 | 3.9532-22.055 | 0 | 4.851 | 1.8673-12.603 | 0.0012 | ≥10 |
|
|